Ceftriaxone IM Prophylaxis for Minor Surgical Procedures
For minor surgical procedures, administer ceftriaxone 1 gram intramuscularly as a single dose 30-60 minutes before the procedure. 1, 2, 3
Standard Dosing Protocol
Adults should receive 1 gram IM as a single preoperative dose, administered 30 minutes to 2 hours before the surgical incision. 1, 3 This dosing is based on the FDA-approved labeling for surgical prophylaxis and is supported by multiple international surgical prophylaxis guidelines. 3, 1
- The 1-gram dose provides plasma concentrations exceeding the minimum inhibitory concentrations (MICs) of most staphylococci, streptococci, and Enterobacteriaceae for 12-24 hours after administration. 4
- Peak plasma concentrations of approximately 81 micrograms/ml are achieved after 1 gram IM injection, with a plasma half-life of 8.3 hours. 4
- Plasma concentrations remain therapeutic for the duration of most minor surgical procedures without requiring redosing. 4, 5
Pediatric Dosing
Children should receive 50 mg/kg IM as a single dose (maximum 1 gram), administered 30-60 minutes before the procedure. 1, 2, 3
- The pediatric dose should not exceed the adult dose of 1 gram regardless of weight. 1, 3
- For children weighing ≥45 kg, use the standard adult dose of 1 gram IM. 6
Anatomic Location Considerations
The anatomic site of surgery determines whether monotherapy is sufficient or combination therapy is required:
- For procedures on the trunk or extremities (away from axilla/perineum): Ceftriaxone 1 gram IM alone is adequate. 7, 2
- For procedures in the axilla or perineal region: Add metronidazole 500 mg IV every 8 hours to provide anaerobic coverage, as these areas have higher risk of polymicrobial infection including anaerobes. 7, 2
- For procedures involving intestinal or genitourinary tract: Add metronidazole 500 mg IV every 8 hours for anaerobic coverage. 7
Critical Contraindications and Precautions
Do not use ceftriaxone in patients with history of anaphylaxis, angioedema, or urticaria to penicillins or ampicillin. 1, 2 While cephalosporins can be used in patients with non-severe penicillin allergies, severe IgE-mediated reactions represent an absolute contraindication. 1
Do not use ceftriaxone monotherapy for MRSA coverage. 7, 2 Ceftriaxone has no activity against methicillin-resistant staphylococci; if MRSA is suspected based on local epidemiology or patient risk factors, add vancomycin 15 mg/kg IV every 12 hours. 7, 2
Avoid diluents containing calcium for reconstitution. 3 Do not use Ringer's solution or Hartmann's solution, as precipitation of ceftriaxone-calcium can occur. 3
Administration Technique
Reconstitute the 1-gram vial with 3.6 mL of diluent to achieve a concentration of 250 mg/mL, or with 2.1 mL to achieve 350 mg/mL. 3
- Inject the diluent into the vial and shake thoroughly to form solution. 3
- Withdraw entire contents into syringe to equal the total labeled dose. 3
- Inject deeply into the body of a large muscle mass; aspiration helps avoid unintentional intravascular injection. 3
- Patients should be informed that intramuscular injection of ceftriaxone is painful. 1
Evidence Supporting Single-Dose Prophylaxis
The efficacy of single-dose ceftriaxone prophylaxis is well-established. 8 In open heart surgery, a single 1-gram preoperative dose of ceftriaxone was equivalent to seven doses of cefazolin administered perioperatively, with no significant difference in infectious complications. 8 For closed fractures requiring osteosynthesis, single-dose prophylaxis reduced postoperative infection rates from 8.3% to 3.6% (P < 0.001). 2
Common Pitfalls to Avoid
- Do not extend prophylaxis beyond the operative period. 1, 3 Postoperative administration beyond 24 hours is unnecessary and potentially harmful, increasing antibiotic resistance without improving outcomes. 9
- Do not substitute ceftriaxone monotherapy for proper surgical technique. 2 Antibiotic prophylaxis does not replace adequate aseptic technique and surgical site preparation. 2
- Do not use ceftriaxone for procedures with high pseudomonal risk. 10 While ceftriaxone has some activity against Pseudomonas aeruginosa, it cannot be recommended as sole therapy in pseudomonal infections. 10